Accepted for/Published in: Journal of Medical Internet Research
Date Submitted: Dec 30, 2023
Date Accepted: Aug 15, 2024
Efficacy of WeChat-Based Digital Intervention versus Metformin for Women with Polycystic Ovary Syndrome: Randomized Controlled Trial
ABSTRACT
Background:
The first-line treatment for polycystic ovary syndrome (PCOS) is lifestyle modification. However, it is currently unknown whether digital medicine can assist PCOS patients in keeping healthy lifestyle while alleviating PCOS symptoms.
Objective:
This study aimed to evaluate the efficacy of digital intervention versus metformin treatment for women with PCOS and insulin resistance.
Methods:
A total of 80 women with PCOS and insulin resistance were randomly assigned to receive either digital intervention (n = 40) or metformin (n = 40) for 12 weeks. The primary outcomes were the changes in the homeostatic model assessment for insulin resistance (HOMA-IR). Anthropometric parameters, menstruation frequency, sex hormone levels, metabolic factors, body fat distribution, and questionnaires on diet, exercise, sleep, anxiety and depression were obtained.
Results:
A total of 72 participants completed the follow-up (90% follow-up rate), including 35 and 37 from the digital intervention and metformin groups, respectively. The HOMA-IR of the digital intervention group was significantly improved after a 12-week of treatment, but no statistical difference was observed between the groups. Both digital intervention and metformin significantly improved menstruation, and reduced body weight and total fat mass. Furthermore, the digital intervention had a significant advantage over metformin in improving waist circumference, waist–hip ratio, total fat mass, and dehydroepiandrosterone sulfate (DHEAS). In terms of safety, the main adverse events in the digital intervention and metformin groups were sensations of hunger (5%) and gastrointestinal adverse events (30%), respectively.
Conclusions:
Our data suggest that digital intervention is an effective treatment option for patients with PCOS, with an efficacy comparable to that of metformin, which can also alleviate the negative effects of medications and make it easier and more efficient to adhere to lifestyle treatments. Clinical Trial: ClinicalTrials.gov NCT05386706; https://clinicaltrials.gov/study/NCT05386706.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.